Search for Clinical Trial Results
IgA Nephropathy - 30 Studies Found
Status | Study |
Completed |
Study Name: The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy Condition: IgA Nephropathy Date: 2011-10-07 Interventions: Drug: Prednisone or Prednisolone daily single dose of 1mg/kg (maximum 80mg) or alternate day single dose |
Recruiting |
Study Name: Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy Condition: Primary IgA Nephropathy Date: 2016-04-30 Interventions:
|
Recruiting |
Study Name: IgA Nephropathy Biomarkers Evaluation Study (INTEREST) Condition:
Date: 2016-11-02 Interventions: Other: No intervention No intervention |
Completed |
Study Name: Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of Immunoglobulin A Nephropathy Condition: IgA Nephropathy Date: 2007-10-25 Interventions: Drug: Omega-3 fatty acid ethylester90 Dosage form :1g soft capsule Dosage : two capsules, twice a day. |
Completed |
Study Name: Probiotics in IgA Nephropathy Condition: IgA Nephropathy Date: 2013-01-16 Interventions:
|
RECRUITING |
Study Name: Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy Condition: IgA Nephropathy Date: 2024-05-19 Interventions: Period A (12 Weeks) - Film-coated tablet, Washout Period: 12 weeks, Period B (24 Weeks) - Placebo |
RECRUITING |
Study Name: A Study to Evaluate the Efficacy and Safety of RO7434656 in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression Condition: Primary IgA Nephropathy Date: 2024-05-19 Interventions: RO7434656 will be administered subcutaneously per schedule as specified. |
RECRUITING |
Study Name: A Study of BION-1301 in Adults With IgA Nephropathy Condition: IgA Nephropathy Date: 2024-05-19 Interventions: BION-1301 Pre-Filled Syringe (PFS) 600mg subcutaneous administration every 2 weeks for 104 weeks. |
RECRUITING |
Study Name: Atacicept in Subjects With IgA Nephropathy Condition: IgA Nephropathy Date: 2024-05-19 Interventions: Once weekly subcutaneous (SC) injections by prefilled syringe |
RECRUITING |
Study Name: A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects Condition: IgA Nephropathy Date: 2024-05-19 Interventions: Oral administration of specified dose of HS-10390 |